Drug recall D-0518-2024
Product
Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04
Reason for recall
Defective container: lack of seal integrity.
Lots and codes
Lot #F305184, F305185, F305186, Exp 7/31/ 2025
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 51,006 bottles
- Distribution
- USA Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 8, 2024
- Terminated
- April 29, 2025
Related products
- Cefdinir – drug information
- NDC 68180-723 Cefdinir · Cefdinir 250 mg/5mL · Lupin Pharmaceuticals, Inc.
- NDC 68180-722 Cefdinir · Cefdinir 125 mg/5mL · Lupin Pharmaceuticals, Inc.